Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - macrogol '3350'; sodium; chloride; bicarbonate; potassium - powder for oral solution - 105gram/1litre ; 65mmol/1litre ; 53mmol/1litre ; 17mmol/1litre ; 5.4mmol/1litre

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - macrogol '3350'; sodium; chloride; bicarbonate; potassium - powder for oral solution - 105gram/1litre ; 65mmol/1litre ; 53mmol/1litre ; 17mmol/1litre ; 5.4mmol/1litre

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - lauromacrogol 400, quantity: 60 mg - injection, solution - excipient ingredients: ethanol; dibasic sodium phosphate dihydrate; monobasic potassium phosphate; water for injections - indications: the solutions are indicated for the treatment of varicose veins (up to 6mm diameter) of the lower limbs by compression sclerotherapy.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - lauromacrogol 400, quantity: 40 mg - injection, solution - excipient ingredients: ethanol; dibasic sodium phosphate dihydrate; monobasic potassium phosphate; water for injections - indications: the solutions are indicated for the treatment of varicose veins (up to 6mm diameter) of the lower limbs by compression sclerotherapy.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - lauromacrogol 400, quantity: 20 mg - injection, solution - excipient ingredients: ethanol; dibasic sodium phosphate dihydrate; monobasic potassium phosphate; water for injections - indications: the solutions are indicated for the treatment of varicose veins (up to 6mm diameter) of the lower limbs by compression. sclerotherapy.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - lauromacrogol 400, quantity: 10 mg - injection, solution - excipient ingredients: ethanol; dibasic sodium phosphate dihydrate; monobasic potassium phosphate; water for injections - indications: the solutions are indicated for the treatment of varicose veins (up to 6mm diameter) of the lower limbs by compression sclerotherapy.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - cytarabine, quantity: 4000 mg - injection, solution - excipient ingredients: water for injections; macrogol 400; trometamol - cytarabine is indicated primarily for:,? induction and maintenance of remission in acute myelocytic leukaemia of both adults and children.,it has also been found to be useful in the treatment of other leukaemias such as:,? acute lymphocytic leukaemia,? chronic myelocytic leukaemia (blast phase).,cytarabine may be used alone or in combination with other antineoplastic agents, the best results are often obtained with combination therapy.,children with non-hodgkin?s lymphoma have benefited from a combination drug program (lsa2l2) that includes cytarabine.,remissions induced by cytarabine not followed by maintenance treatment have been brief. maintenance therapy has extended these and provided useful and comfortable remissions with relatively little toxicity.,cytarabine has been used intrathecally in meningeal leukaemia. focal leukaemic involvement of the central nervous system may not respond to intrathecal cytarabine and may better be treated with radiotherapy.

Kenía - enska - Pharmacy and Poisons Board

macrogol, sodium chloride, sodium bicarbonate,… - powder for oral solution - macrogol 3350 13.125g sodium chloride 350.7mg… - macrogol combinations

Japan - enska - すりの適正使用協議会 RAD-AR Council, Japan

maruishi pharmaceutical. co., ltd. - macrogol ointment - white ointment

Malasía - enska - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ep plus group sdn. bhd. - macrogol 4,000 -